patient intakeworkflowpeptidesGLP-1automation

Patient Intake Workflows for Peptide and GLP-1 Clinics

A detailed look at the ideal patient intake workflow for clinics offering peptide therapy and GLP-1 programs. From first contact to first prescription, with strategies for automation, AI triage, and operational efficiency.

C
Chad H.
Updated May 31, 2026 13 min read
On this page

The patient intake workflow is where most clinics either establish operational efficiency or create bottlenecks that limit growth. For practices running peptide therapy and GLP-1 weight loss programs, the intake process repeats for every new patient, making optimization critical as patient volume grows.

This guide details the ideal intake workflow from first patient contact to first prescription shipped, with specific attention to automation opportunities, AI-powered clinical review, and the operational decisions that determine whether your practice can handle 20 patients or 200.

Why Intake Workflow Matters

The intake workflow directly impacts three critical practice metrics:

1. Patient conversion rate. Every friction point in intake causes patient drop-off. A patient who fills out an interest form but never completes intake is lost revenue. Streamlined intake converts more inquiries into active patients.

2. Staff and provider time per patient. If each new patient requires 45 minutes of staff time for form processing, chart building, and clinical review, your team capacity limits growth. At 10 new patients per week, that is 7.5 hours of staff time consumed by intake alone.

3. Time to first prescription. Patients who wait days or weeks between intake and receiving medication are more likely to lose motivation, seek alternatives, or cancel. Speed matters for retention and satisfaction.

The Complete Intake Workflow

Phase 1: Patient Acquisition and Initial Contact

The workflow begins when a potential patient first engages with your practice.

Channels of initial contact:

  • Website inquiry form
  • Phone call to practice
  • Social media direct message
  • Referral from existing patient
  • Online advertising landing page

Best practice: Regardless of initial contact channel, direct patients to a single digital entry point (intake form URL or patient portal link). This standardizes the workflow and ensures no patients fall through cracks between channels.

Automation opportunity: Auto-responder emails or SMS messages that immediately provide the intake link after initial inquiry. No staff intervention needed.

Phase 2: Digital Intake Forms

Once directed to intake, the patient completes a detailed digital questionnaire. This replaces paper forms, phone-based intake, and manual data collection. The Office of the National Coordinator for Health IT (ONC) has established standards for electronic health information capture that inform best practices in digital intake design.

Essential intake form sections:

Demographics and Contact Information

  • Full name, date of birth, address
  • Phone number, email address
  • Preferred communication method
  • Emergency contact

Medical History

  • Active medical conditions (with specific screening for contraindications)
  • Surgical history
  • Current medications and supplements (with dosages)
  • Known allergies (medication, food, environmental)
  • Family medical history (relevant conditions)
  • Prior hormone or peptide therapy experience

Program-Specific Screening

For GLP-1 programs:

  • Current weight, height, BMI calculation
  • Weight loss history and prior interventions
  • History of pancreatitis, medullary thyroid carcinoma, MEN2 syndrome
  • Current diabetes medications (insulin, sulfonylureas require dose adjustment)
  • Gastrointestinal conditions
  • Pregnancy status or plans
  • Eating disorder history

For peptide therapy programs:

  • Treatment goals (recovery, immune support, body composition, anti-aging)
  • Prior peptide use and response
  • Current health optimization protocols
  • Relevant lab work (within last 6 months)
  • Injection experience and comfort level

Lifestyle and Goals

  • Treatment objectives (specific and measurable)
  • Exercise habits
  • Dietary patterns
  • Sleep quality
  • Stress levels
  • Expectations and timeline
  • Informed consent for compounded medications
  • Telehealth consent (if applicable)
  • Financial agreement and program terms
  • HIPAA acknowledgment
  • Cancellation and refund policy

Regulatory note on consent: The FDA’s guidance on compounded drugs emphasizes that patients should understand they are receiving a compounded product that has not been reviewed by the FDA for safety, efficacy, or quality. The FDA’s draft guidance on clinical documentation for compounded medications further outlines documentation expectations for prescribers of compounded preparations. Your consent forms should clearly communicate this distinction.

Form design principles:

  • Mobile-optimized: 70%+ of patients complete forms on mobile devices
  • Conditional logic: Show relevant questions based on prior answers (do not show GLP-1-specific questions to peptide-only patients)
  • Progress indicators: Patients need to know how far they are through the form
  • Save and resume: Allow patients to pause and return if forms are lengthy
  • Plain language: Avoid medical jargon in patient-facing questions
  • Required vs. optional fields: Mark clearly; minimize required fields to what is clinically essential

Completion time target: 10 to 15 minutes for a thorough intake

Phase 3: Clinical Review and Triage

Once the patient submits their intake, the clinical review process begins. This is where automation has the greatest impact on practice efficiency.

Traditional (Manual) Clinical Review

In a traditional workflow, the provider or clinical staff:

  1. Opens the submitted intake form
  2. Reads through all responses manually
  3. Cross-references medications for interactions
  4. Checks for contraindications against prescribing criteria
  5. Reviews medical history for red flags
  6. Documents findings in the patient chart
  7. Makes a determination: approve, request more information, or decline
  8. Communicates the decision

Time per patient: 15 to 30 minutes Scalability: Limited to 8 to 15 new patients per day per reviewer

AI-Powered Clinical Review

AI-assisted review transforms this process:

  1. Automated data extraction: AI parses intake responses into structured clinical data
  2. Contraindication screening: System automatically flags absolute and relative contraindications based on published guidelines
  3. Drug interaction check: Cross-references current medications against the intended prescription
  4. Risk stratification: Categorizes patients as low-risk (straightforward), moderate-risk (needs provider attention), or high-risk (requires detailed review or referral)
  5. Clinical summary generation: Produces a concise provider-facing summary with relevant findings highlighted
  6. Provider approval: Licensed prescriber reviews the AI-generated summary and makes the final clinical decision

Time per patient: 3 to 7 minutes of provider time Scalability: 40 to 80+ new patients per day per provider

Studies published in the Journal of the American Medical Informatics Association (JAMIA) have demonstrated that clinical decision support systems can reduce intake processing time by 50% or more while maintaining or improving documentation quality.

The FDA’s framework for AI in healthcare recognizes the role of clinical decision support tools that augment (rather than replace) provider judgment. AI triage systems that present information for provider approval align with this framework.

Triage Outcomes

Every intake resolves to one of four outcomes:

  1. Approved for prescribing: Patient meets all criteria, no concerns identified. Proceed to prescription.
  2. Approved with conditions: Patient is appropriate but needs lab work, dose modification, or specific monitoring before or during treatment.
  3. Additional information needed: Intake is incomplete or specific clarifications are required before a clinical decision can be made.
  4. Declined or referred: Patient has contraindications, is not an appropriate candidate, or needs evaluation by a specialist.

Automation opportunity: Outcome-specific automated communications. Approved patients receive next steps immediately. Patients needing additional information receive specific questions. No manual follow-up required for routine outcomes.

Phase 4: Prescribing

Once clinical review is complete and the patient is approved, the prescription is generated and sent to the pharmacy.

Prescribing Workflow Elements

  1. Protocol selection: Provider selects the appropriate medication, dose, and protocol based on clinical review
  2. Prescription generation: System generates the prescription with all required fields (patient info, medication, sig, quantity, refills, prescriber credentials)
  3. Pharmacy routing: Prescription is transmitted electronically to the designated compounding pharmacy
  4. Documentation: Prescription details are recorded in the patient record
  5. Patient notification: Patient is informed that their prescription has been sent

One-Click Prescribing

Modern platforms reduce prescribing to a single action for straightforward cases:

  • AI recommends the protocol based on clinical data (e.g., semaglutide 0.25 mg starting dose for a new GLP-1 patient with BMI 32)
  • Provider reviews and approves with one click
  • System handles pharmacy transmission, documentation, and patient notification automatically

Time per prescription: 1 to 2 minutes with one-click prescribing vs. 5 to 10 minutes with manual processes

Phase 5: Pharmacy Fulfillment

After the prescription reaches the compounding pharmacy, fulfillment begins.

Typical fulfillment timeline:

  1. Pharmacy receives prescription: Same day (electronic transmission)
  2. Pharmacy processes and compounds: 1 to 3 business days
  3. Shipping: 1 to 3 business days (overnight available)
  4. Patient receives medication: 3 to 5 business days total

Tracking and communication:

  • Pharmacy confirms prescription receipt
  • Shipping notification with tracking number sent to patient
  • Delivery confirmation
  • Practice is notified of any fulfillment issues (out of stock, address problems)

Automation opportunity: Integrated fulfillment tracking that automatically updates patients without staff intervention. Patients receive SMS or email updates as their medication moves through processing and shipping.

Phase 6: Patient Onboarding

Once the patient receives their medication, onboarding ensures they know how to use it properly and what to expect.

Onboarding communication should include:

  • Injection technique instructions (video preferred for subcutaneous injections)
  • Dosing schedule and titration timeline
  • Expected side effects and management strategies
  • When to contact the provider (red flag symptoms)
  • Program structure (check-in schedule, dose adjustments, lab requirements)
  • How to request refills or communicate questions

Delivery method: Automated email sequence triggered by delivery confirmation, supplemented with video content and a patient resource portal.

HIPAA and Data Security in Digital Intake

Digital intake workflows must comply with HIPAA Privacy and Security Rules. The HHS Security Rule guidance provides specific technical safeguards that apply to any platform collecting patient health information electronically. Key requirements:

  • Encrypted data transmission: All patient-submitted forms must use TLS encryption
  • Access controls: Only authorized staff can view patient intake data
  • Business Associate Agreements: Required with any third-party platform handling patient information
  • Data retention policies: Define how long intake data is stored and how it is disposed
  • Patient access rights: Patients can request copies of their submitted information

When evaluating intake platforms, verify HIPAA compliance documentation and ensure a BAA is in place before processing any patient data.

Measuring Intake Workflow Performance

Key Metrics

MetricTargetWhy It Matters
Form completion rate70%+Measures intake friction
Time from inquiry to form startUnder 1 hourSpeed of initial engagement
Time from form submission to clinical reviewUnder 4 hoursReview queue efficiency
Time from approval to prescription sentUnder 1 hourPrescribing workflow speed
Time from inquiry to medication deliveredUnder 7 daysTotal patient experience
Patient drop-off rate (inquiry to enrollment)Under 40%Overall funnel health
Provider time per new patientUnder 7 minutesOperational scalability

Common Bottlenecks and Solutions

Bottleneck: Low form completion rates

  • Solution: Shorten forms, add mobile optimization, use conditional logic, enable save-and-resume

Bottleneck: Slow clinical review

  • Solution: Implement AI pre-screening, establish review SLA (same business day), batch reviews during dedicated time blocks

Bottleneck: Pharmacy delays

  • Solution: Use pharmacies with electronic ordering integration, establish relationships with multiple pharmacies for redundancy, monitor fulfillment times

Bottleneck: Patient confusion after approval

  • Solution: Automated next-step communications, clear timeline setting, proactive status updates

Scaling Your Intake Workflow

From 20 to 50 Patients Per Month

At this volume, basic automation handles most of the load:

  • Digital forms replace paper and phone intake
  • Template-based clinical review (provider uses checklists)
  • Standard protocols reduce prescribing decisions to selection from 3 to 5 options
  • Automated patient communications for routine touchpoints

From 50 to 200 Patients Per Month

At this volume, AI-powered automation becomes essential:

  • AI clinical review with provider approval (not manual chart review)
  • Automated triage routing (straightforward cases vs. complex cases)
  • One-click prescribing for standard protocols
  • Integrated fulfillment tracking eliminates manual pharmacy follow-up
  • Exception-based workflow (staff only handles non-routine situations)

From 200+ Patients Per Month

At high volume, the system must handle complexity at scale:

  • Multi-provider workflows with role-based access
  • Advanced analytics on funnel performance
  • Automated quality assurance checks
  • Integration with CRM for patient relationship management
  • Custom reporting for compliance and operational oversight

How Karpa Health Optimizes Intake

Karpa Health was built specifically for the intake-to-fulfillment workflow that peptide and GLP-1 practices need:

  • Customizable digital intake forms with conditional logic and mobile optimization
  • AI-powered clinical review that pre-screens patients and presents provider-ready summaries
  • Contraindication and interaction checking against full clinical databases
  • One-click prescribing with protocol templates for common medications
  • Automated pharmacy routing to integrated compounding pharmacy partners including Empower Pharmacy and Olympia Pharmacy
  • Real-time fulfillment tracking with automated patient notifications
  • Patient portal for self-service access to program information and communication

The platform reduces per-patient intake time from 45+ minutes (staff and provider combined) to under 7 minutes of provider time, enabling practices to scale without proportional staffing increases.

Implementation Recommendations

For practices building or optimizing their intake workflow:

  1. Start with the patient experience. Complete your own intake form as a test patient. Note every friction point, confusing question, or unnecessary step.

  2. Eliminate manual handoffs. Every time information passes from one system or person to another, errors and delays occur. Integrated systems that flow data automatically outperform cobbled-together tool stacks.

  3. Measure everything from day one. You cannot optimize what you do not measure. Track the metrics listed above starting with your first patient.

  4. Automate communications first. The highest-impact automation is not clinical (that requires more sophistication) but communicational. Automated emails, status updates, and next-step instructions dramatically reduce staff time and improve patient experience.

  5. Reserve provider time for clinical decisions. Everything that does not require a licensed prescriber’s judgment should be automated or delegated. Provider time is your most expensive and limited resource.

The practices that build efficient intake workflows early compound that advantage as they grow. A practice with a 7-minute-per-patient workflow can add 30 new patients per week with a single part-time provider. A practice with a 45-minute workflow hits a wall at 10 patients per week unless they hire additional staff.

Operational efficiency is not just about cost savings. It determines your growth ceiling.

For related guidance, see our article on HIPAA compliance for cash-pay programs to ensure your intake workflow meets privacy requirements. If you are evaluating pharmacy partners for fulfillment, our direct-to-patient pharmacy fulfillment guide covers shipping models and logistics.

For more context on closely related topics, read automated patient follow-up guide.

Book a call with Karpa Health if you want help structuring the right program.

Frequently Asked Questions

How long should the intake process take for a new peptide or GLP-1 patient?
With an optimized digital workflow, the patient-facing intake (forms, history, consent) should take 10 to 15 minutes of the patient's time. The clinical review and prescribing decision should take 3 to 7 minutes of provider time with AI-assisted pre-screening. Total time from intake submission to prescription sent should be under 24 hours for straightforward cases.
What medical history information is essential for peptide and GLP-1 prescribing?
At minimum: current medications (especially insulin, sulfonylureas, blood thinners), allergies, active medical conditions (thyroid disease, pancreatitis history, MEN2 syndrome for GLP-1), prior hormone or peptide use, pregnancy status, and relevant surgical history. A thorough intake form should also capture lifestyle factors, treatment goals, and prior lab results if available.
Can AI really replace clinical review for these patients?
AI does not replace clinical judgment. It augments it. AI-powered clinical review pre-screens intake data, flags contraindications, checks drug interactions, and presents a summary for provider approval. The licensed prescriber always makes the final decision. What AI eliminates is the manual chart review, data entry, and information gathering that consumes most of the provider's time.
What consent documentation is required for peptide therapy?
Informed consent should cover: the compounded nature of the medication (not FDA-approved as a finished product), expected benefits and timeline, potential side effects and risks, injection technique and self-administration instructions, monitoring requirements, and the patient's right to discontinue at any time. Some states have specific compounding consent requirements. Consult your state pharmacy board guidelines.

Related Program

Ready to launch your Peptide Therapy Program?

Try for Free
Chad H.

Written by

Chad H.

Co-founder of Karpa Health. Builds and operates turnkey telehealth infrastructure for clinicians and entrepreneurs launching cash-pay specialty programs including peptide therapy, GLP-1 weight loss, TRT, and HRT across all 50 states.

Learn more about Karpa

Related Articles

Streamline Your Cash-Pay Programs

Karpa handles patient intake, provider workflows, pharmacy fulfillment, and billing so your team can focus on patient care.